On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. case to determine whether appellate courts should afford any deference to a trial court's claim construction...more
10/15/2014
/ Claim Construction ,
De Novo Standard of Review ,
Facebook ,
Google ,
Intel ,
Non-Practicing Entities ,
Patent Assertion Entities ,
Patent Litigation ,
Patent Trolls ,
Patents ,
Pharmaceutical Patents ,
SCOTUS ,
Teva v Sandoz ,
Verizon